- Investing Ideas
- Japanese Biotech Breakthroughs
Japanese Biotech Breakthroughs
Results
6
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
6 companies
SanBio
Market Cap: JP¥172.4b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.
4592
JP¥2,209.00
7D
-2.2%
1Y
89.0%
Noile-Immune Biotech
Market Cap: JP¥7.3b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥168.00
7D
7.7%
1Y
0.6%
GNI Group
Market Cap: JP¥169.2b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥3,040.00
7D
6.3%
1Y
-9.8%
Healios K.K
Market Cap: JP¥62.8b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥465.00
7D
29.9%
1Y
50.0%
Japan Tissue Engineering
Market Cap: JP¥31.2b
Engages in the regenerative medicine business in Japan.
7774
JP¥768.00
7D
21.7%
1Y
54.8%
Takara Bio
Market Cap: JP¥138.1b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥1,147.00
7D
-0.09%
1Y
36.5%